after a qtrly CC? I would think that people who are thinking that a FINANCIAL flavored conf call is going to move a stock like this up are going to be disappointed. The financials of R&D companies always suck......it's to be expected so I don't think Thursday will help at all unfortunately. Unless they are going to get into specific drug data results on the call in the "highlights" part of it. The meeting in June however could be more meaningful. good luck to all.
this is a biotech stock.. FDA plays that are so close to approval and the ASCO meeting as well as the fast track granted, I would not pump and dump this stock.. you may miss the boat. If you have time and patience buy this stock and hold..It will reward you..